Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.
D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D004110:Diltiazem / Q000494:pharmacology; D006327:Heart Block / Q000188:drug therapy*; D006801:Humans; D007473:Ion Channels; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009543:Nifedipine / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D014700:Verapamil / Q000494:pharmacology
D007473:Ion Channels; D012964:Sodium; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium